EIF2AK3 and neurodegenerative disease: Dysregulation of the UPR/PERK/eIF2α signaling pathway now has been identified as a potential contributing factor to pathophysiology associated with neurodegenerative diseases, and PERK has emerged as a potential novel therapeutic target.